SCHEMBL12070655

SCHEMBL12070655

COc1cc2cc(-c3cc(C)c(OC)c(-c4ccccc4)c3)[nH]c(=O)c2cc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ TNKS O95271 3/20 0.41
▸ TNKS2 Q9H2K2 2/20 0.41
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41
▸ GUSB P08236 1/20 0.40
▸ RET P07949 1/20 0.39
▸ PARP2 Q9UGN5 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927039 0.86 TNKS (0.38) KMT2AMEN1NPC1RAB9AATM
SCHEMBL12070664 0.85 NQO2 (0.42) KMT2AMEN1NPC1RAB9AATM
SCHEMBL31611876 0.84 TNKS (0.51) KMT2AMEN1NPC1RAB9AATM
SCHEMBL12071547 0.83 PDE3B (0.48) KMT2AMEN1NPC1RAB9AATM
SCHEMBL14927044 0.81 KMT2A (0.40) KMT2AMEN1NPC1RAB9AATM
SCHEMBL16499568 0.79 PDE10A (0.47) KMT2AMEN1NPC1RAB9AATM
SCHEMBL9986595 0.79 PDE10A (0.47) KMT2AMEN1NPC1RAB9AATM
SCHEMBL31589365 0.71 KDM4E (0.50) KMT2AMEN1TNKSTNKS2PDE3B
SCHEMBL14927077 0.71 KDM4E (0.46) NPC1RAB9ATNKSTNKS2KDM4E
SCHEMBL8499922 0.69 PDGFRB (0.45) KMT2AMEN1TNKSTNKS2PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed
WO-2011159926-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-12-22 — — WO disclosed
WO-2011156626-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 KMT2A 3183/4885MEN1 1251/4885NPC1 1513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback